公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2016 | Comparisons of genetic alterations of breast cancer between East and West: Special emphases on young patients with ER /HER2tumors | CHIU-HSUN LIN; Lu, TP; RUBY YUN-JU HUANG ; Lu, YS; Lo, KY; Kuo, KT; Chuang, EY; Wu, PF; Chen, IC; Thiery, JP; Huang, CS; Cheng, AL | CANCER RESEARCH | 0 | 0 | |
2005 | Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors. | Lu, YS; Lien, HC; Yeh, PY; Kun-Huei, Yeh; Kuo, ML; Kuo, SH; Cheng, AL | World J Gastroenterol | | | |
2011 | Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001 | Kuo, SH; Hsu, CH; Chen, LT; Lu, YS; Lin, CH; Yeh, PY; Jeng, HJ; Gao, M; Yeh, KH; Cheng, AL | EUROPEAN JOURNAL OF CANCER | 0 | 0 | |
2004 | Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma. | Lu, YS; Hsu, C; Li, CC; Kuo, SH; Kun-Huei, Yeh; Yang, CH; Hsu, CH; Wu, CY; Cheng, AL. | Hepatogastroenterology | | | |
2005 | Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer. | Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL. | Oncology | | | |
2005 | Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer. | Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL. | Oncology | | | |
2005 | Phase II study of weekly vinorelbine and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer. | Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Cheng, AL. | Br J Cancer | | | |
2005 | Phase II study of weekly vinorelbine and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer. | Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Cheng, AL. | Br J Cancer | | | |